logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xiao-Dong Jiao

naval medical university
H指数:20
被引数:1,352

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial

安罗替尼联合信迪利单抗作为晚期结直肠癌患者的一线治疗（APICAL-CRC）：一项开放标签、单臂、II期试验

Signal Transduction and Targeted Therapy
IF52.7
2025-09-160
OAAI
Zhan Wang; Bao-Dong Qin; Chen-Yang Ye; Miao-Miao Wang; Ling-Yan Yuan; Hou-Shan Yao; Xiao-Dong Jiao; Ke Liu; Wen-Li Zhou; Wen-Xing Qin; Li Sun; Wei-Ping Dai; Yan Ling; Ying Wu; Shi-Qi Chen; Ying-Fu Zhang; Dong-Min Shi; Xiao-Peng Duan; Xue Zhong; Xi He; Wen-Xin Zhai; Bei Zhang; Da-Dong Zhang; Ning Gao; Yuan-Sheng Zang
Efficacy and safety of anlotinib plus toripalimab as first-line regimen in advanced gastric cancer patients with performance status 2 (PS 2): An open-label, single arm, phase II trial

安罗替尼联合特瑞普利单抗作为一线方案在体力状况2级（PS 2）晚期胃癌患者中的疗效与安全性：一项开放标签、单臂、II期临床试验

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Liu, K.; Qin, B.; Chen, S.; Zhong, X.; Duan, X.; Wu, Y.; Ling, Y.; Sun, L.; Shi, D.; Jiao, X.; Zang, Y.
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)
FRONTIERS IN ONCOLOGY
IF3.3
2023-02-233
OAAI
Jiao, Xiao-Dong; Qin, Bao-Dong; Wang, Zhan; Liu, Ke; Wu, Ying; Ling, Yan; Qin, Wen-Xing; Wang, Miao-Miao; Yuan, Ling-Yan; Barreto, Savio George; Kim, Anthony W.; Mak, Kimberley; Li, Hao; Xu, Yuan-Yuan; Qiu, Xiao-Ming; Wu, Min; Jin, Min; Xu, Li-Chao; Zhong, Yi; Yang, Hui; Chen, Xue-Qin; Zeng, Yu; Shi, Jun; Zhu, Wen-Yu; Ding, Qing-Qing; Jia, Wei; Liu, Su-Fen; Zhou, Jun-Jing; Shen, Hong; Yao, Shi-Hua; Guo, Zhao-Ji; Li, Ting; Zhou, Pei-Juan; Dong, Xue-Wei; Lu, Wen-Feng; Coleman, Robert L.; Akce, Mehmet; Akladios, Cherif; Puccetti, Francesco; Zang, Yuan-Sheng
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial

西妥昔单抗和维罗非尼联合FOLFIRI (5-氟尿嘧啶/亚叶酸钙/伊立替康) 治疗BRAF V600E-mutated晚期结直肠癌 (改善): 一项开放标签，单臂，II期试验

EUROPEAN JOURNAL OF CANCER
IF7.1
2022-03-0113
PRE
Wang, Zhan; Qin, Bao-Dong; Ye, Chen-Yang; Wang, Miao-Miao; Yuan, Ling-Yan; Dai, Wei-Ping; Sun, Li; Liu, Ke; Qin, Wen-Xing; Jiao, Xiao-Dong; Li, Xing-Nan; Zang, Yuan-Sheng
Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

血液小胞外囊泡来源的miRNAs鉴别胰腺导管腺癌与慢性胰腺炎

CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2021-09-1016
OAAI
Guo, Shiwei; Qin, Hao; Liu, Ke; Wang, Huan; Bai, Sijia; Liu, Shiyi; Shao, Zhuo; Zhang, Yanan; Song, Bin; Xu, Xiaoya; Shen, Jing; Zeng, Peng; Shi, Xiaohan; Chen, Hao; Gao, Suizhi; Xu, Jiajia; Pan, Yaqi; Xiong, Lei; Li, Fugen; Zhang, Dadong; Jiao, Xiaodong; Jin, Gang
Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma
TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2021-07-015
OAAI
Jiao, Xiao-Dong; Ding, Li-Ren; Zhang, Chuan-Tao; Qin, Bao-Dong; Liu, Ke; Jiang, Lian-Ping; Wang, Xi; Lv, Li-Ting; Ding, Hao; Li, Dao-Ming; Yang, Hui; Chen, Xue-Qin; Zhu, Wen-Yu; Wu, Ying; Ling, Yan; He, Xi; Liu, Jun; Shao, Lin; Wang, Hao-Zhe; Chen, Yan; Zheng, Jing-Jing; Inui, Naoki; Zang, Yuan-Sheng

研究方向

暂未获取到该数据
B
Bao‐Dong Qin
H 指数:27论文数:130被引数:4,397
Y
Yuan‐Sheng Zang
H 指数:21论文数:101被引数:1,420
W
Wenxing Qin
H 指数:20论文数:68被引数:1,079
刘克 封面图
刘克
H 指数:62论文数:620被引数:1.4万
Y
Yan Ling
H 指数:24论文数:125被引数:1,836
X
Xiaopeng Duan
H 指数:29论文数:97被引数:3,214
L
Lingyan Yuan
H 指数:11论文数:42被引数:309
刘
刘珂
H 指数:50论文数:476被引数:1.0万
Z
Zhan Wang
H 指数:25论文数:152被引数:2,071
Z
Zhan Wang
H 指数:20论文数:189被引数:1,884